Why Baddi Is Becoming a Major Hub for Injectable Pharma Manufacturing
Why Demand for Injectable Medicines Is Growing Hospital treatments, emergency care, and critical care medicines are increasing the demand for injectable products across India. According to IMARC Group, India’s pharmaceutical market is expected to cross USD 130 billion by 2030, and injectable medicines are becoming a fast-growing part of the industry. According to IBEF (India Brand Equity Foundation) The generic injectable market in India was valued at Rs. 25,965 crore (US$ 3.0 billion) in 2024 and is anticipated to grow at a compound annual growth rate (CAGR) of 10.28% to reach Rs. 65,778 crore (US$ 7.6 billion) by 2033. This growing demand is one reason many pharma businesses now care more about manufacturing quality and reliable supply instead of choosing manufacturers only based on low pricing. Why Pharma Businesses Prefer Baddi Strong pharma infrastructure and large-scale manufacturing are the biggest reasons Baddi has become one of India’s best-known pharmaceutical m...